Please note: This website includes an accessibility system. Press Control-F11 to adjust the website to people with visual disabilities who are using a screen reader; Press Control-F10 to open an accessibility menu.
The FDA has approved the first-ever vaccine for the respiratory syncytial virus (RSV). Every year, the virus hospitalizes between 60,000-180,000 Americans over the age of
The FDA’s independent advisory panel voted in favor of two vaccines for respiratory syncytial virus (RSV). The vaccines, developed by GSK and Pfizer for people